Cimetidine Alternatives Compared
Cimetidine Remove Cimetidine from your drug comparison | Aldara Remove Aldara from your drug comparison | Imiquimod topical Remove Imiquimod topical from your drug comparison |
---|
Cimetidine Remove Cimetidine from your drug comparison | Aldara imiquimod Remove Aldara from your drug comparison | Imiquimod topical Remove Imiquimod topical from your drug comparison | ||||||||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Prescribed for GERD, Duodenal Ulcer, Erosive Esophagitis, Duodenal Ulcer Prophylaxis, Cutaneous Mastocytosis, Human Papilloma Virus, Indigestion, Stomach Ulcer, Stress Ulcer Prophylaxis, Upper GI... View more |
Prescribed for Basal Cell Carcinoma, Keratosis, Human Papilloma Virus, Condylomata Acuminata. May also be prescribed off label for Molluscum Contagiosum. |
Prescribed for Basal Cell Carcinoma, Keratosis, Human Papilloma Virus, Condylomata Acuminata. May also be prescribed off label for Molluscum Contagiosum. |
||||||||||||||||||||||||
Prescription and OTC |
Prescription only |
Prescription only |
||||||||||||||||||||||||
Ratings & Reviews |
||||||||||||||||||||||||||
Drug Class |
||||||||||||||||||||||||||
Side Effects |
||||||||||||||||||||||||||
See the full cimetidine side effects document. |
Common side effects include: dermal ulcer, abrasion, application site reaction, burning sensation, desquamation, edema, exfoliation of skin, pruritus, skin erosion, erythema of skin. See the full Aldara side effects document. |
Commonly reported side effects include: dermal ulcer, abrasion, application site reaction, burning sensation, desquamation, edema, exfoliation of skin, pruritus, skin erosion, erythema of skin. See the full imiquimod topical side effects document. |
||||||||||||||||||||||||
Pricing and Coupons* Prices are without insurance |
||||||||||||||||||||||||||
View all cimetidine prices |
View all Aldara prices and generic prices |
View all imiquimod topical prices |
||||||||||||||||||||||||
Generic Availability |
||||||||||||||||||||||||||
Yes (this medicine) |
Yes (this medicine) |
|||||||||||||||||||||||||
Dosage Form(s) Available |
||||||||||||||||||||||||||
|
|
|
||||||||||||||||||||||||
Brand Names |
||||||||||||||||||||||||||
Acid Reducer-Cimetidine, Equaline Acid Reducer, Leader Heartburn Relief, Tagamet HB | Other imiquimod brands include: Zyclara | Aldara, Zyclara | ||||||||||||||||||||||||
Half LifeThe half-life of a drug is the time taken for the plasma concentration of a drug to reduce to half its original value. |
||||||||||||||||||||||||||
2.5 hours |
N/A |
N/A |
||||||||||||||||||||||||
CSA Schedule**View glossary of terms. |
||||||||||||||||||||||||||
Not a controlled drug
Is not subject to the Controlled Substances Act. |
Not a controlled drug
Is not subject to the Controlled Substances Act. |
Not a controlled drug
Is not subject to the Controlled Substances Act. |
||||||||||||||||||||||||
Pregnancy Category |
||||||||||||||||||||||||||
Category B
No proven risk in humans
See the full Pregnancy Warnings document. |
Category C
Risk cannot be ruled out
See the full Pregnancy Warnings document. |
Category C
Risk cannot be ruled out
See the full Pregnancy Warnings document. |
||||||||||||||||||||||||
FDA Alerts |
||||||||||||||||||||||||||
N/A |
N/A |
N/A |
||||||||||||||||||||||||
Drug Interactions |
||||||||||||||||||||||||||
A total of 425 drugs are known to interact with cimetidine:
|
A total of 6 drugs are known to interact with Aldara:
|
A total of 6 drugs are known to interact with imiquimod topical:
|
||||||||||||||||||||||||
Alcohol/Food/Lifestyle Interactions |
||||||||||||||||||||||||||
No known alcohol/food interactions. This does not necessarily mean no interactions exist. Always consult your healthcare provider. |
No known alcohol/food interactions. This does not necessarily mean no interactions exist. Always consult your healthcare provider. |
No known alcohol/food interactions. This does not necessarily mean no interactions exist. Always consult your healthcare provider. |
||||||||||||||||||||||||
Disease Interactions |
||||||||||||||||||||||||||
First Approval Date |
||||||||||||||||||||||||||
August 16, 1977 |
February 27, 1997 |
February 27, 1997 |
||||||||||||||||||||||||
WADA ClassView World Anti-Doping Agency classifications. |
||||||||||||||||||||||||||
N/A |
N/A |
N/A |
||||||||||||||||||||||||
More Information |
||||||||||||||||||||||||||
Consumer Resources |
||||||||||||||||||||||||||
N/A |
||||||||||||||||||||||||||
Professional Resources |
||||||||||||||||||||||||||
Related Treatment Guide |
||||||||||||||||||||||||||
** The Controlled Substances Act (CSA) schedule information displayed applies to substances regulated under federal law. There may be variations in CSA schedules between individual states.
Further information
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.